PRNewswire

DF9001 is currently being evaluated for the treatment of Non-Small Cell Lung Cancer, Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma DF6215 is currently being evaluated for the treatment of advanced solid tumors BOSTON, Nov. 7, 2024 /PRNewswire/ — Dragonfly Therapeutics, Inc.,

SINGAPORE, Nov. 7, 2024 /PRNewswire/ — At GFI’s Networking and Partners Appreciation Night, the Global Fintech Institute (GFI) launched the Chartered Fintech Associate (CFtA) certification and signed a Memorandum of Understanding with the Banking and Financial Services Union (BFSU), an a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: